Skip to main content
logo
Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
16.16
-0.15 (-0.95%)
Jul 28, 2026, 4:00 PM EDT - Market closed

Rallybio Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.860.860.64---
Revenue Growth
1.18%34.91%----
Gross Profit
0.860.860.64---
Operating Income
-32.13-33.06-60.5-78.93-67.88-45.65
Net Income
-7.82-8.98-57.78-74.56-66.65-47.01
Earnings Per Share
-1.37-1.59-10.61-14.72-16.72-14.72
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
46.854.7465.51109.93168.99175.33
Total Debt
0.150.180.150.390.560
Net Cash (Debt)
46.6454.5665.36109.54168.44175.33
Net Cash Growth
-14.23%-16.52%-40.33%-34.97%-3.93%25.03%
Net Cash Per Share
8.259.6912.0121.6742.3554.97

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-27.59-29.81-49.28-60.27-57.28-45.53
Capital Expenditures
----0.01-0.05-0.33
Free Cash Flow
-27.59-29.81-49.28-60.28-57.34-45.87
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%---
Operating Margin
-3744.41%-3853.61%-9511.95%---
Pretax Margin
-911.07%-1046.39%-9084.12%---
Profit Margin
-911.07%-1046.39%-9084.12%---
FCF Margin
-3215.15%-3474.71%-7748.74%---

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
99.7633.8062.66---